Article | October 27, 2022

How Biopharma Can Address Specialized Skills Gaps And Improve Resilience

Source: Cytiva
Laboratory research GettyImages-1291232203

Throughout the COVID-19 pandemic, the biopharma industry has faced numerous challenges. From drug supply shortages to lack of biomanufacturing capacity, a multitude of factors have affected and continue to affect populations worldwide. Improving the global biomanufacturing supply chain remains a top priority, as lessons learned from the pandemic continue to emerge. One of the weakest areas for improvement in the industry is access to talent. A skills gap is capable of slowing production and even making manufacturing errors. Learn how the combination of advanced digital learning technology and professional training and education programs is key for training local talent and securing biomanufacturing resilience.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development